Imaging in head and neck squamous cell carcinoma: The potential role of PET/MRI

British Journal of Radiology

Volumn 87, Issue 1036, 2014, Pages

  Becker, Minerva ^a   Zaidi, Habib ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK TUMOR; HUMAN; LUNG DISEASE; LUNG NODULE; METHODOLOGY; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REVIEW; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CLINICAL PROTOCOLS; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; SOLITARY PULMONARY NODULE;

EID: 84907484364     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130677     Document Type: Review

References (100)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008; 371: 1695-709. doi: 10.1016/S0140-6736 (08)60728-X
2. Calabrese L, Ostuni A, Ansarin M, Giugliano G, Maffini F, Alterio D, et al. Future challenges in head and neck cancer: from the bench to the bedside? Crit Rev Oncol Hematol 2012; 84(Suppl. 1): e90-6. doi: 10.1016/j. critrevonc.2010.11.001
3. Richards PS, Peacock TE. The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging. 2007; 7: 167-78. doi: 10.1102/1470-7330.2007.0024
4. Becker M, Zbären P, Casselman JW, Kohler R, Dulguerov P, Becker CD. Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology 2008; 249: 551-9. doi: 10.1148/ radiol.2492072183
5. Becker M, Burkhardt K, Dulguerov P, Allal A. Imaging of the larynx and hypopharynx. Eur J Radiol 2008; 66: 460-79. doi: 10.1016/ j.ejrad.2008.03.027
6. Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, et al. 18Ffluorodeoxyglucose- PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology 2009; 51: 677-86. doi: 10.1007/ s00234-009-0586-8
7. Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology 2012; 263: 19-32. doi: 10.1148/radiol.11101821
8. Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009; 251: 134-46. doi: 10.1148/ radiol.2511080128
9. Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-andneck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 1098-107. doi: 10.1016/j.ijrobp.2011.02.044
10. Tshering Vogel DW, Zbaeren P, Geretschlaeger A, Vermathen P, De Keyzer F, Thoeny HC. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 2013; 23: 562-9.
11. Pichler BJ, Kolb A, Nagele T, Schlemmer HP. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 2010; 51: 333-6. doi: 10.2967/jnumed.109.061853
12. Boss A, Stegger L, Bisdas S, Kolb A, Schwenzer N, Pfister M, et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol 2011; 21: 1439-46. doi: 10.1007/s00330- 011-2072-z
13. von Schulthess GK, Kuhn FP, Kaufmann P, Veit-Haibach P. Clinical positron emission tomography/magnetic resonance imaging applications. Semin Nucl Med 2013; 43: 3-10. doi: 10.1053/j. semnuclmed.2012.08.005
14. Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009; 2009: 208725. doi: 10.1155/2009/208725
15. Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ. Contrast-enhanced (1)(8)F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck 2011; 33: 324-9. doi: 10.1002/hed.21447
16. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000; 27: 643-6.
17. Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDGPET. Eur J Nucl Med Mol Imaging 2002; 29: 1639-47. doi: 10.1007/s00259-002-0924-0
18. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 2010; 195: 310-20. doi: 10.2214/AJR.10.4923
19. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004; 45: 1519-27.
20. Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 2008; 30: 889-97. doi: 10.1002/hed.20790
21. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008; 33: 210-22. doi: 10.1111/j.1749- 4486.2008.01688.x
22. Schoder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med 2009; 50(Suppl. 1): 74S-88S. doi: 10.2967/jnumed.108.057208
23. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucosepositron- emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol 2010; 31: 598-604. doi: 10.3174/ajnr.A1760
24. Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol 2007; 85: 327-35. doi: 10.1016/j.radonc.2007.11.002
25. Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, et al. Clinical significance of postradiotherapy [18F]- fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer: a long-term outcome report. Int J Radiat Oncol Biol Phys 2009; 74: 9-14. doi: 10.1016/j. ijrobp.2008.07.019
26. Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006; 24: 4371-6.
27. Baek CH, Chung MK, Son YI, Choi JY, Kim HJ, Yim YJ, et al. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images. J Nucl Med 2008; 49: 1422-8. doi: 10.2967/jnumed.108.051649
28. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005; 46: 1136-43.
29. Hustinx R, Lucignani G. PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 2010; 37: 645-51. doi: 10.1007/s00259-009-1365-9
30. Iyer NG, Clark JR, Singham S, Zhu J. Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers. Head Neck 2010; 32:1202-8. doi: 10.1002/ hed.21319
31. Krabbe CA, Balink H, Roodenburg JL, Dol J, de Visscher JG. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx. Int J Oral Maxillofac Surg 2011; 40: 1263-70. doi: 10.1016/j. ijom.2011.06.023
32. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993; 250: 11-17.
33. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43: 871-5.
34. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-17.
35. Carlson ER, Schaefferkoetter J, Townsend D, McCoy JM, Campbell PD Jr, Long M. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes. J Oral Maxillofac Surg 2013; 71: 162-77.
36. Stoeckli SJ, Haerle SK, Strobel K, Haile SR, Hany TF, Schuknecht B. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck 2012; 34: 469-76. doi: 10.1002/hed.21764
37. Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009; 50: 24-9. doi: 10.2967/jnumed.108.055806
38. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 2009; 36: 12-22. doi: 10.1007/s00259-008-0918-7
39. Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004; 101: 2641-9. doi: 10.1002/cncr.20687
40. Schinagl DA, Span PN, van den Hoogen FJ, Merkx MA, Slootweg PJ, Oyen WJ, et al. Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer. Eur J Nucl Med Mol Imaging 2013; 40 1828-35. doi: 10.1007/s00259- 013-2513-9
41. Chawla SC, Federman N, Zhang D, Nagata K, Nuthakki S, McNitt-Gray M, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5- year retrospective review. Pediatr Radiol 2010; 40: 681-6. doi: 10.1007/s00247-009- 1434-z
42. Maroldi R, Farina D, Borghesi A, Marconi A, Gatti E. Perineural tumor spread. Neuroimaging Clin N Am 2008; 18: 413-29, xi. doi: 10.1016/j.nic.2008.01.001
43. Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Eur J Radiol 2006; 60: 58-66. doi: 10.1016/j.ejrad.2006.05.019
44. Zhang GY, Liu LZ, Wei WH, Deng YM, Li YZ, Liu XW. Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology 2010; 255: 605-12.
45. Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology 1995; 194: 661-9. doi: 10.1148/radiology.194.3.7862960
46. Curtin HD. The "evil gray": cancer and cartilage. Radiology 2008; 249: 410-12. doi: 10.1148/radiol.2492081113
47. Ljumanovic R, Langendijk JA, vanWattingen M, Schenk B, Knol DL, Leemans CR, et al. MR imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone. Radiology 2007; 244: 205-12. doi: 10.1148/radiol.2441060593
48. Ljumanovic R, Langendijk JA, Hoekstra OS, Knol DL, Leemans CR, Castelijns JA. Preand post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma. Eur Radiol 2008; 18: 2231-40. doi: 10.1007/s00330-008-0986-x
49. Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008; 249: 203-11. doi: 10.1148/ radiol.2491071753
50. Kwee TC, Takahara T, Ochiai R, Koh DM, Ohno Y, Nakanishi K, et al. Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med 2010; 51: 1549-58. doi: 10.2967/ jnumed.109.073908
51. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-35. doi: 10.2214/ AJR.06.1403
52. Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, et al. Diffusionweighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009; 15: 986-94. doi: 10.1158/ 1078-0432.CCR-08-1287
53. Fushimi Y, Miki Y, Okada T, Yamamoto A, Mori N, Hanakawa T, et al. Fractional anisotropy and mean diffusivity: comparison between 3.0-T and 1.5-T diffusion tensor imaging with parallel imaging using histogram and region of interest analysis. NMR Biomed 2007; 20: 743-8.
54. Varoquaux A, Rager O, Lovblad KO, Masterson K, Dulguerov P, Ratib O, et al. Functional imaging of head and neck squamous cell carcinoma with diffusionweighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013; 40: 842-52. doi: 10.1007/s00259-013-2351-9
55. Koh DM, Blackledge M, Padhani AR, Takahara T, Kwee TC, Leach MO, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 2012; 199: 252-62. doi: 10.2214/ AJR.11.7866
56. Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, et al. Higher sensitivity and specificity for diffusionweighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252: 247-54.
57. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505. doi: 10.1148/ radiology.168.2.3393671
58. Martínez Barbero J, Rodríquez Jiménez I, Martin Noguerol T, Luna Alcalá A. Utility of MRI diffusion techniques in the evaluation of tumors of the head and neck. Cancers 2013; 5: 875-89. doi: 10.3390/ cancers5030875
59. Rheinheimer S, Stieltjes B, Schneider F, Simon D, Pahernik S, Kauczor HU, et al. Investigation of renal lesions by diffusionweighted magnetic resonance imaging applying intravoxel incoherent motionderived parameters: initial experience. Eur J Radiol 2012; 81: e310-16.
60. Hauser T, Essig M, Jensen A, Gerigk L, Laun FB, Munter M, et al. Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters: preliminary results. Neuroradiology 2013; 55: 527-36.
61. Verhappen MH, Pouwels PJ, Ljumanovic R, van der Putten L, Knol DL, De Bree R, et al. Diffusion-weighted MR imaging in head and neck cancer: comparison between half- Fourier acquired single-shot turbo spinecho and EPI techniques. AJNR Am J Neuroradiol 2012; 33: 1239-46. doi: 10.3174/ajnr.A2949
62. Ichikawa Y, Sumi M, Sasaki M, Sumi T, Nakamura T. Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol 2012; 33: 761-6.
63. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998; 207: 123-30. doi: 10.1148/ radiology.207.1.9530307
64. Herneth AM, Mayerhoefer M, Schernthaner R, Ba-Ssalamah A, Czerny Ch, Fruehwald-Pallamar J. Diffusion weighted imaging: lymph nodes. Eur J Radiol 2010; 76: 398-406. doi: 10.1016/j.ejrad.2010.08.016
65. Zbaren P, Nuyens M, Curschmann J, Stauffer E. Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas. Head Neck 2007; 29: 26-32.
66. Zbaren P, Christe A, Caversaccio MD, Stauffer E, Thoeny HC. Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg 2007; 137: 487-91.
67. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994; 35:2011-18.
68. Leibfarth S, Monnich D, Welz S, Siegel C, Schwenzer N, Schmidt H, et al. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning. Acta Oncol 2013; 52: 1353-9. doi: 10.3109/ 0284186X.2013.813964
69. Schoenfeld JD, Kovalchuk N, Subramaniam RM, Truong MT. PET/CT of cancer patients: part 2, deformable registration imaging before and after chemotherapy for radiation treatment planning in head and neck cancer. AJR Am J Roentgenol 2012; 199: 968-74.
70. Wurslin C, Schmidt H, Martirosian P, Brendle C, Boss A, Schwenzer NF, et al. Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med 2013; 54: 464-71. doi: 10.2967/jnumed.112.105296
71. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, et al. First clinical experience with integrated wholebody PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012; 53: 845-55.
72. Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/ MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med 2012; 53: 928-38. doi: 10.2967/ jnumed.112.105338
73. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008; 14: 459-65. doi: 10.1038/ nm1700
74. Schlemmer HP, Pichler BJ, Schmand M, Burbar Z, Michel C, Ladebeck R, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 2008; 248: 1028-35. doi: 10.1148/ radiol.2483071927
75. Zaidi H. Is MR-guided attenuation correction a viable option for dual-modality PET/ MR imaging? Radiology 2007; 244: 639-42. doi: 10.1148/radiol.2443070092
76. Eiber M, Martinez-Moller A, Souvatzoglou M, Holzapfel K, Pickhard A, Loffelbein D, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging 2011; 38: 1691-701. doi: 10.1007/s00259-011-1842-9
77. Eiber M, Souvatzoglou M, Pickhard A, Loeffelbein DJ, Knopf A, Holzapfel K, et al. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction. Eur J Radiol 2012; 81: 2658-65. doi: 10.1016/j. ejrad.2011.10.005
78. Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011; 52: 1914-22. doi: 10.2967/ jnumed.111.092726
79. Martinez-Moller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 2009; 50: 520-6. doi: 10.2967/ jnumed.108.054726
80. Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: methods and challenges. MAGMA 2013; 26: 99-113. doi: 10.1007/s10334-012-0353-4
81. Vargas MI, Becker M, Garibotto V, Heinzer S, Loubeyre P, Gariani J, et al. Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies. MAGMA 2013; 26: 57-69. doi: 10.1007/s10334-012- 0340-9
82. Varoquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, et al. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 2014; 41: 462-75. doi: 10.1007/s00259-013- 2580-y
83. Ratib O, Beyer T. Whole-body hybrid PET/ MRI: ready for clinical use? Eur J Nucl Med Mol Imaging 2011; 38: 992-5. doi: 10.1007/ s00259-011-1790-4
84. Zaidi H, Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys 2011; 38: 5667-89. doi: 10.1118/ 1.3633909
85. Zaidi H, Ojha N, Morich M, Griesmer J, Hu Z, Maniawski P, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 2011; 56: 3091-106. doi: 10.1088/0031- 9155/56/10/013
86. Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G. PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. MAGMA 2013; 26: 25-35. doi: 10.1007/s10334-012-0344-5
87. Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Langner J, Schramm G, et al. PET/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging 2013; 40: 6-11. doi: 10.1007/s00259-012- 2248-z
88. Wiesmuller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging 2013; 40: 12-21. doi: 10.1007/ s00259-012-2249-y
89. Bini J, Izquierdo-Garcia D, Mateo J, Machac J, Narula J, Fuster V, et al. Preclinical evaluation of MR attenuation correction versus CT attenuation correction on a sequential whole-body MR/PET scanner. Invest Radiol 2013; 48: 313-22. doi: 10.1097/ RLI.0b013e31827a49ba
90. Klinke T, Daboul A, Maron J, Gredes T, Puls R, Jaghsi A, et al. Artifacts in magnetic resonance imaging and computed tomography caused by dental materials. PLoS One 2012; 7: e31766. doi: 10.1371/journal. pone.0031766
91. Huang H, Ceritoglu C, Li X, Qiu A, Miller MI, van Zijl PC, et al. Correction of B0 susceptibility induced distortion in diffusion-weighted images using largedeformation diffeomorphic metric mapping. Magn Reson Imaging 2008; 26: 1294-302. doi: 10.1016/j.mri.2008.03.005
92. Ruthotto L, Kugel H, Olesch J, Fischer B, Modersitzki J, Burger M, et al. Diffeomorphic susceptibility artifact correction of diffusion-weighted magnetic resonance images. Phys Med Biol 2012; 57: 5715-31. doi: 10.1088/0031-9155/57/18/5715
93. Buchbender C, Hartung-Knemeyer V, Forsting M, Antoch G, Heusner TA. Positron emission tomography (PET) attenuation correction artefacts in PET/CT and PET/MRI. Br J Radiol 2013; 86: 20120570. doi: 10.1259/bjr.20120570
94. Park HH, Shin JY, Lee J, Jin GH, Kim HS, Lyu KY, et al. A study on the artifacts generated by dental materials in PET/CT image. Conf Proc IEEE Eng Med Biol Soc 2013; 2013: 2465-8. doi: 10.1109/ EMBC.2013.6610039
95. Abdoli M, Ay MR, Ahmadian A, Dierckx RA, Zaidi H. Reduction of dental filling metallic artifacts in CT-based attenuation correction of PET data using weighted virtual sinograms optimized by a genetic algorithm. Med Phys 2010; 37: 6166-77.
96. Delso G,Wollenweber S, Lonn A, Wiesinger F, Veit-Haibach P. MR-driven metal artifact reduction in PET/CT. Phys Med Biol 2013; 58: 2267-80. doi: 10.1088/0031-9155/58/7/2267
97. Nakamoto Y, Tamai K, Saga T, Higashi T, Hara T, Suga T, et al. Clinical value of image fusion from MR and PET in patients with head and neck cancer. Mol Imaging Biol 2009; 11: 46-53. doi: 10.1007/s11307-008- 0168-x
98. Huang S-H, Chien C-Y, Lin W-C, Fang F-M, Wang P-W, Lui C-C, et al. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma. Clin Nucl Med 2011; 36: 518-25. doi: 10.1097/ RLU.0b013e318217566f
99. Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, et al. Value of retrospective image fusion of F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Eur J Radiol 2013; 82: 2005-10. doi: 10.1016/j. ejrad.2013.06.025
100. Appenzeller P, Mader C, Huellner MW, Schmidt D, Schmid D, Boss A, et al. PET/CT versus body coil PET/MRI: how low can you go? Insights Imaging 2013; 4: 481-90. doi: 10.1007/s13244- 013-0247-7